Medco Says “Drug Switching” Charges Are Old News, Should Be Dismissed
Executive Summary
Medco believes its 1998 consent agreement with the Federal Trade Commission should protect the company from "whistleblower" allegations that it engaged in inappropriate drug switching practices
You may also be interested in...
Medco Prosecution Will Continue Under False Claims Act, Kickback Laws
Medco's handling of mail-order services as a subcontractor to the Blue Cross Blue Shield Association for the Federal Employees Health Benefit Program is liable to prosecution under the False Claims Act, a Philadelphia federal court judge ruled Sept. 23
Medco Prosecution Will Continue Under False Claims Act, Kickback Laws
Medco's handling of mail-order services as a subcontractor to the Blue Cross Blue Shield Association for the Federal Employees Health Benefit Program is liable to prosecution under the False Claims Act, a Philadelphia federal court judge ruled Sept. 23
Medco Prosecutor Exceeds Boundaries Of False Claims Act, PBM Says
The Philadelphia U.S. Attorney's lawsuit against Medco presses claims that fall outside the boundaries of health care fraud law, the pharmacy benefit manager maintains in a dismissal motion filed Dec. 19